Aurinia Pharmaceuticals (AUPH) Shares Tick Lower Early Following Strong Session

October 7, 2016 8:46 AM EDT
Get Alerts AUPH Hot Sheet
Trade AUPH Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Aurinia Pharmaceuticals (NASDAQ: AUPH) shares are seeing a bit of pullback on Friday following a 26 percent gain on Thursday. The stock is down just over 3 percent.

Yesterday, Aurinia Pharma announced 24-week data in all 10 patients from the AURION study, an open-label exploratory study to assess the short-term predictors of response using voclosporin (23.7mg BID) in combination with mycophenolate mofetil (MMF) and oral corticosteroids in patients with active lupus nephritis (LN). For more color ,click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment